Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Quetiapine impurity 15

Quetiapine impurity 15 is listed in the pharmaceutical impurity collection under CAS 628-89-7. Its represented structure has formula C4H9ClO2 and a calculated molecular weight of 124.57 g/mol.

2D chemical structure

H O O C l

Chemical identity

Catalog name
Quetiapine impurity 15
Common name
Quetiapine impurity 15
Chemical name
2-(2-chloroethoxy)ethanol
CAS
628-89-7
SMILES
OCCOCCCl
InChI
InChI=1S/C4H9ClO2/c5-1-3-7-4-2-6/h6H,1-4H2
InChIKey
LECMBPWEOVZHKN-UHFFFAOYSA-N
Associated API
Quetiapine

Record ID: A57aa4757959b

Computed properties

C4H9ClO2 Molecular formula
124.567 g/molMolecular weight
124.0291 DaMonoisotopic exact mass
29.46 ŲTopological polar surface area
0.2341 Calculated LogP (Wildman–Crippen)
28.6248 cm³/molMolar refractivity (Wildman–Crippen)
2 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H O 0 2 4 6 8 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight124.5672.48
Calculated LogP (Wildman–Crippen)0.234116.06
Topological polar surface area29.4613.08
Hydrogen-bond acceptors215.92
Hydrogen-bond donors138.08
Rotatable bonds (strict)449.39

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC4H9ClO2dimensionless
Molecular weight124.567g/mol
Monoisotopic exact mass124.0291Da
Topological polar surface area29.46Ų
Calculated LogP (Wildman–Crippen)0.2341dimensionless
Molar refractivity (Wildman–Crippen)28.6248cm³/mol
Hydrogen-bond acceptors2count
Hydrogen-bond donors1count
Rotatable bonds (strict)4count
Heavy atoms7count
Heteroatoms3count
Rings0count
Aromatic rings0count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles0count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms1fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area48.0451Ų
Valence electrons44count
Radical electrons0count
Bertz complexity28.8708index
Balaban J2.4475index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Quetiapine impurity 15

Qualification and safety assessment of Quetiapine impurity 15

Explore toxicological qualification of Quetiapine impurity 15 and ICH M7 mutagenic impurity assessment of Quetiapine impurity 15 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Quetiapine impurity 15 and acceptable intake and limit justification for Quetiapine impurity 15. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Quetiapine impurity 15

Explore Altox services and software through the Altox Pharma-Hub.